Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

2018

Slider News

2018

  • 2018 - 03 - 09

    The Menarini Group announced marketing authorization Application for delafloxacin

  • 2018 - 03 - 12

    Menarini hires their 17,000th employee

  • 2018 - 03 - 22

    Menarini announces new governance

  • 2018 - 04 - 13

    Menarini Ricerche to present the most recent pre-clinical data about the PI3K inhibitor MEN1611 at the AACR Annual Meeting 2018.

  • 2018 - 04 - 16

    Menarini chooses Google Cloud for its digital transformation

  • 2018 - 05 - 03

    The intelligence coming from being together … Menarini creates, invents, and offers games for Florence’s youngest citizens!

  • 2018 - 05 - 17

    The Menarini art series emboldened by the courage of Artemisia

  • 2018 - 06 - 01

    Menarini Ricerche to present the Study design of CD205-Shuttle, a first-in-human trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

  • 2018 - 06 - 08

    Teamwork Makes the Dream Work

  • Layout 1

    2018 - 06 - 15

    Violence against women, You need the right words to say the right things

  • 2018 - 07 - 04

    The XXII edition of the Fair Play Menarini International Award gets underway

  • 2018 - 07 - 18

    The stars of the Fair Play light up the sky on Menarini’s gala dinner

  • 2018 - 08 - 06

    Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA

  • 2018 - 09 - 05

    MENARINI: new investment in Tuscany

  • 2018 - 09 - 19

    Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting

  • 2018 - 09 - 24

    Press Release

  • 2018 - 10 - 11

    The MENARINI GROUP Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries

  • 2018 - 10 - 16

    Menarini and the maggio musicale fiorentino together in social project

  • 2018 - 10 - 19

    Menarini progresses into the Clinic with MEN1611, a PI3K inhibitor for the treatment of HER2 positive metastatic breast cancer.

  • 2018 - 10 - 25

    Art in a click: Menarini launches “Pills of Art”

  • 2018 - 10 - 29

    Menarini, new Board Member appointed

  • Pieghevole 24_09_corr04.pdf

    2018 - 11 - 09

    Press Release

  • 2018 - 11 - 20

    Artemisia Gentileschi. La forza dal dolore

  • 2018 - 11 - 27

    Menarini vince il premio "Firenze nel cuore corporate 2018"

  • 2018 - 12 - 07

    Menarini a Pomezia con “la giornata dei talenti”

  • 2018 - 12 - 20

    The Menarini Group announces meropenem/vaborbactam European marketing authorization

  • 2018 - 12 - 21

    Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat